ATYR PHARMA, INC. reports a Return on Equity (ROE) of -120.88%.

What is ATYR's dividend yield?

ATYR PHARMA, INC. offers a dividend yield of 0.00%.

What is ATYR's Deepscope Quality Score?

Deepscope rates ATYR's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ATYR?

Deepscope's AI Timing Score for ATYR is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ATYR belong to?

ATYR PHARMA, INC. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Cổ phiếu ATYR (NASDAQ) | ATYR PHARMA, INC.

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-11 | FS: 2026-03-31)

ATYR

ATYR PHARMA, INC.

US:NASDAQ STOCK Healthcare >> Biotechnology News 53

USD 0.48

0.01 (1.49%) Day Change

Watchlist Portfolio Compare Chart

0.03

D/E

-120.9%

ROE

-87.9%

ROA

0.00%

Div Yield

ATYR PHARMA, INC.
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.48 Price 0.01 (1.49%) Day Change	NEWS SCORE: 53

ATYR Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 23) và Thời điểm mua ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...

Yếu tố Chất lượng

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	53
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.48
PBV / Sector	0.80 / 4.79 GREAT
Earning Per Share	-0.72

PE / Sector	N/A / 18.05
PEG or PE/Growth / Sector	N/A / 0.62
Average 1M Daily Value	1.81 M GREAT
Average 1W Daily Value	0.78 M GREAT

Yếu tố Kỹ thuật

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-36,857.37 / 468.85
NPM Average (%) / Sector	-23,564.34 / -1,531.69
NPM Change Average (%) / Sector	824.63 / 5,028.65 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-87.92 / 31.69
ROA Average (%) / Sector	-64.37 / -353.18
ROA Change Average (%) / Sector	19.32 / 5,214.65 GOOD
ROE (%) / Sector	-120.88 / 10.58
ROE Average (%) / Sector	-88.23 / 27.64
ROE Change Average (%) / Sector	20.57 / 2,048.88 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.77

Chi tiết đăng ký

Analyze Date	2026-06-12 09:43:50
Symbol	ATYR
Name	ATYR PHARMA, INC.
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	98.05 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	45.93 / 9,010.81

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 10240 Sorrento Valley Road, San Diego, CA, United States, 92121

Phone: 858 731 8389

Website: https://atyrpharma.com

Employees: 58

Sector: Healthcare >> Biotechnology

Description: aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; Phase 2 clinical trial to treat Sarcoidosis and systemic sclerosis- interstitial lung disease (ILDs); and treatment of other ILDs, such as chronic hypersensitivity pneumonitis (CHP) and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase, which is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.